Latest filing published 18 Feb 2026 for Baxter International INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael R. Mcdonnell, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Biogen Inc., Merit Medical Systems Inc and Baxter International Inc. We count 17 filings; the first trade dates from 1 September 2021 and the latest from 13 February 2026.
Every open-market trade on record is a sale: 1 sale worth €145k. Other entries cover 5 share grants and 11 option exercises.
The newest entry dates from 18 February 2026: a share grant, in Baxter International Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations